secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001479681-25-000024
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health Q1 revenue surges 214% to $211.8M; net income $14.6M vs loss $0.4M
-------------------------------------------------------------------------------

- Diluted EPS $2.56 vs ($0.08) in Q1 2024; EBITDA $43.1M (+507% YoY).
- Arbitration process added ~$105M in revenue, 73% of total revenue increase.
- Stock-based compensation $36.1M (non-cash, one-time) weighed on GAAP net income.
- Cash from operations $51.0M; cash balance $87.7M, long-term debt $21.7M.
- Hospital visits up 20.5% YoY; mature hospitals revenue rose 186.5%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000147968125000024/0001479681-25-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000147968125000024/nutx-20250513x8k.htm
  HTML page:      https://secwatch.observer/filing/0001479681-25-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer